Effect of oral and transdermal hormone therapy on hyaluronic acid in women with and without a history of intrahepatic cholestasis of pregnancy

American Journal of Obstetrics and Gynecology

Volumn 198, Issue 4, 2008, Pages 375.e1-375.e5

  Tuomikoski, Pauliina ^a   Aittomäki, Kristiina ^a   Mikkola, Tomi S ^a   Ropponen, Anne ^a   Ylikorkala, Olavi ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

hormone therapy; hyaluronic acid; intrahepatic cholestasis of pregnancy; liver disease

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; ESTRADIOL; GAMMA GLUTAMYLTRANSFERASE; HYALURONIC ACID; MEDROXYPROGESTERONE ACETATE; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; ESTROGEN DEFICIENCY; FEMALE; HORMONAL THERAPY; HORMONE RESPONSE; HUMAN; INTRAHEPATIC CHOLESTASIS; LIVER FIBROSIS; PREGNANCY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRANSDERMAL PATCH; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 41349121337     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2007.10.804     Document Type: Article

References (25)

1. Fraser J.R., Laurent T.C., and Laurent U.B. Hyaluronan: Its nature, distribution, functions and turnover. J Intern Med 242 (1997) 27-33
2. Sakugawa H., Nakayoshi T., Kobashigawa K., et al. Clinical usefulness of biochemical markers of liver fibrosis in patients with non-alcoholic fatty liver disease. World J Gastroenterol 11 (2005) 255-259
3. Mizuguchi T., Katsuramaki T., Nobuoka T., et al. Serum hyaluronate level for predicting subclinical liver dysfunction after hepatectomy. World J Surg 28 (2004) 971-976
4. Sunil N., Srinivasan N., Aruldhas M.M., and Govindarajulu P. Impact of oestradiol and progesterone on the glycosaminoglycans and their depolymerizing enzymes of the rat mammary gland. Acta Physiol Scand 168 (2000) 385-392
5. Stickel F., Poeschl G., Schuppan D., et al. Serum hyaluronate correlates with histological progression in alcoholic liver disease. Eur J Gastroenterol Hepatol 15 (2003) 945-950
6. George J., and Stern R. Serum hyaluronan and hyaluronidase: very early markers of toxic liver injury. Clin Chim Acta 348 (2004) 189-197
7. Lichtinghagen R., and Bahr M.J. Noninvasive diagnosis of fibrosis in chronic liver disease. Expert Rev Mol Diagn 4 (2004) 715-726
8. de Deus J.M., Girao M.J., Sartori M.G., et al. Glycosaminoglycan profile in bladder and urethra of castrated rats treated with estrogen, progestogen, and raloxifene. Am J Obstet Gynecol 189 (2003) 1654-1659
9. Glantz A., Marschall H.U., Lammert F., and Mattsson L.A. Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid. Hepatology 42 (2005) 1399-1405
10. Lammert F., Marschall H.U., Glantz A., and Matern S. Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management. J Hepatol 33 (2000) 1012-1021
11. Glantz A., Marschall H.U., and Mattsson L.A. Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates. Hepatology 40 (2004) 467-474
12. Ropponen A., Sund R., Riikonen S., Ylikorkala O., and Aittomäki K. Intrahepatic cholestasis of pregnancy as an indicator of liver and biliary diseases: a population-based study. Hepatology 43 (2006) 723-728
13. Painter J.N., Savander M., Ropponen A., et al. Sequence variation in the ATP8B1 gene and intrahepatic cholestasis of pregnancy. Eur J Hum Genet 13 (2005) 435-439
14. Lucena J.F., Herrero J.I., Quiroga J., et al. A multidrug resistance 3 gene mutation causing cholelithiasis, cholestasis of pregnancy, and adulthood biliary cirrhosis. Gastroenterology 124 (2003) 1037-1042
15. Mullenbach R., Linton K.J., Wiltshire S., et al. ABCB4 gene sequence variation in women with intrahepatic cholestasis of pregnancy. J Med Genet 40 (2003) e70
16. Dixon P.H., Weerasekera N., Linton K.J., et al. Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein trafficking. Hum Mol Genet 9 (2000) 1209-1217
17. Jacquemin E. Role of multidrug resistance 3 deficiency in pediatric and adult liver disease: one gene for three diseases. Semin Liver Dis 21 (2001) 551-562
18. Beuers U., and Pusl T. Intrahepatic cholestasis of pregnancy--a heterogeneous group of pregnancy-related disorders?. Hepatology 43 (2006) 647-649
19. Drill V.A. Benign cholestatic jaundice of pregnancy and benign cholestatic jaundice from oral contraceptives. Am J Obstet Gynecol 119 (1974) 165-174
20. Dalen E., and Westerholm B. Occurrence of hepatic impairment in women jaundiced by oral contraceptives and in their mothers and sisters. Acta Med Scand 195 (1974) 459-463
21. Reyes H., and Simon F.R. Intrahepatic cholestasis of pregnancy: An estrogen-related disease. Semin Liver Dis 13 (1993) 289-301
22. Ropponen A., Aittomäki K., Vihma V., Tikkanen M.J., and Ylikorkala O. Effects of oral and transdermal estradiol administration on levels of sex hormone-binding globulin in postmenopausal women with and without a history of intrahepatic cholestasis of pregnancy. J Clin Endocrinol Metab 90 (2005) 3431-3434
23. Ropponen A., Aittomäki K., Tikkanen M.J., and Ylikorkala O. Levels of serum C-reactive protein during oral and transdermal estradiol in postmenopausal women with and without a history of intrahepatic cholestasis of pregnancy. J Clin Endocrinol Metab 90 (2005) 142-146
24. Nelson H.D. Commonly used types of postmenopausal estrogen for treatment of hot flashes: scientific review. JAMA 291 (2004) 1610-1620
25. Notelovitz M. Clinical opinion: the biologic and pharmacologic principles of estrogen therapy for symptomatic menopause. Med Gen Med 8 (2006) 85